Elizabeth A. Morgan
- Oncology top 5%
- Molecular Biology top 10%
- Genetics top 1%
- Pathology and Forensic Medicine top 2%
- Hematology top 2%
- Co-authors
- Lorraine S. SymingtonKatherine N. WeilbaecherAngela C. HirbeSylvie MoreauÖzge UluçkanGeraldine S. PinkusZuzana TóthováAlessandra F. Nascimento
- Topics
- Lymphoma Diagnosis and Treatment (27 papers)Acute Myeloid Leukemia Research (16 papers)Chronic Lymphocytic Leukemia Research (12 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Elizabeth A. Morgan
89 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 119
- Oncology 811
- Molecular Biology 788
- Genetics 682
- Pathology and Forensic Medicine 632
- Hematology 535
Countries citing papers authored by Elizabeth A. Morgan
This map shows the geographic impact of Elizabeth A. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth A. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth A. Morgan more than expected).
Fields of papers citing papers by Elizabeth A. Morgan
This network shows the impact of papers produced by Elizabeth A. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth A. Morgan. The network helps show where Elizabeth A. Morgan may publish in the future.
Co-authorship network of co-authors of Elizabeth A. Morgan
This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth A. Morgan. A scholar is included among the top collaborators of Elizabeth A. Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth A. Morgan. Elizabeth A. Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 4 | |
| 7 | 9 | |
| 8 | 12 | |
| 9 | 9 | |
| 10 | 8 | |
| 11 | 13 | |
| 12 | 227 | |
| 13 | 144 | |
| 14 | 189 | |
| 15 | 46 | |
| 16 | 10 | |
| 17 | 115 | |
| 18 | CLINICAL FEATURES OF YOUNG ONSET PARKINSON'S DISEASE | 1 |
| 19 | 48 | |
| 20 | 48 |
About Elizabeth A. Morgan
Elizabeth A. Morgan is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 93 papers that have together received 2.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (27 papers), Acute Myeloid Leukemia Research (16 papers) and Chronic Lymphocytic Leukemia Research (12 papers). The work is most often cited by research in Genetics (682 citations), Hematology (535 citations) and Pathology and Forensic Medicine (632 citations). Elizabeth A. Morgan has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Lorraine S. Symington, Katherine N. Weilbaecher, Angela C. Hirbe, Sylvie Moreau, Özge Uluçkan, Geraldine S. Pinkus, Zuzana Tóthová, Alessandra F. Nascimento, Jon C. Aster and Julie L. Prior. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.